KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AVRO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Friday for AVROBIO Inc stock after gaining 2.11%
(Updated on Apr 26, 2024)

Sell candidate since Apr 05, 2024 Loss -4.72% PDF

The AVROBIO Inc stock price gained 2.11% on the last trading day (Friday, 26th Apr 2024), rising from $1.19 to $1.21. During the last trading day the stock fluctuated 3.83% from a day low at $1.18 to a day high of $1.22. The price has fallen in 5 of the last 10 days and is down by -4.72% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 110 thousand more shares were traded than the day before. In total, 205 thousand shares were bought and sold for approximately $247.66 thousand.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -5.60% during the next 3 months and, with a 90% probability hold a price between $1.01 and $1.22 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AVRO Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has risen 2.11%. Further rise is indicated until a new top pivot has been found. AVROBIO Inc has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The AVROBIO Inc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.26. On a fall, the stock will find some support from the short-term average at $1.21. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for AVROBIO Inc stock

AVROBIO Inc finds support from accumulated volume at $1.19 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0450 between high and low, or 3.83%. For the last week, the stock has had daily average volatility of 3.23%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AVRO) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect AVROBIO Inc to open at $1.20, and during the day (based on 14 day Average True Range), to move between $1.16 and $1.26, which gives a possible trading interval of +/-$0.0463 (+/-3.83%) up or down from last closing price. If AVROBIO Inc takes out the full calculated possible swing range there will be an estimated 7.65% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.19 (1.65%) than the resistance at $1.26 (4.13%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is AVROBIO Inc stock A Buy?

AVROBIO Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.096 Sell Candidate Unchanged

Predicted Opening Price for AVROBIO Inc of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$1.20 ( 0.689%) $1.21

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AVRO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.25 3.03 %
R2 1.23 1.61 %
R1 1.22 0.732 %
Current price: 1.21
Support S1 1.18 -2.11 %
S2 1.17 -2.99 %
S3 1.16 -4.41 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.31 8.26 %
R2 1.30 7.44 %
R1 1.26 4.13 %
Current price 1.21
Support S1 1.19 -1.65%
S2 1.19 -2.07%
S3 1.15 -4.96%

FAQ

What is the symbol for AVROBIO Inc Stock and on which exchange is it traded?
The symbol for AVROBIO Inc is AVRO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell AVROBIO Inc Stock?
AVROBIO Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy AVROBIO Inc Stock?
AVROBIO Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy AVROBIO Inc Stock.

What's the current price of AVROBIO Inc Stock?
As of the end of day on the Apr 26, 2024, the price of an AVROBIO Inc (AVRO) share was $1.21.

What is the 52-week high and low for AVROBIO Inc Stock?
The 52-week high for AVROBIO Inc Stock is $1.70 and the 52-week low is $0.570.

What is the market capitalization of AVROBIO Inc Stock?
As of the Apr 26, 2024, the market capitalization of AVROBIO Inc is 53.16M.

When is the next earnings date for AVROBIO Inc?
The upcoming earnings date for AVROBIO Inc is May 09, 2024.
Click to get the best stock tips daily for free!

About AVROBIO Inc

AVROBIO AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's product includes AVR-RD-01, a gene therapy for the treatment of Fabry di... AVRO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT